Nuvalent
Lindsey Wilson (Jacobson) currently serves as the Director of Clinical Operations at Nuvalent, Inc. since February 2024. Prior to this role, Lindsey held the position of Director of Clinical Operations at Theseus Pharmaceuticals from October 2021 to November 2023, and served as Associate Director of Clinical Operations in the same company. Lindsey's experience includes a tenure as Senior Clinical Trial Manager at FORMA Therapeutics, Inc., and various roles at ImmunoGen, Inc., Verastem, and AVEO Oncology, where responsibilities ranged from Clinical Trial Manager to Lead Clinical Research Associate. Initial career steps included roles as Study File Analyst at Wyeth Research and Clinical Research Assistant at PAREXEL. Lindsey earned a Bachelor of Science in Biomedical Engineering from the University of Virginia and a Master of Science in Regulatory Affairs for Drugs, Biologics, and Medical Devices from Northeastern University.
This person is not in any teams
This person is not in any offices
Nuvalent
1 followers
Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectivity to overcome resistance, minimize adverse events, and drive more durable responses.